Mouse epidermal growth factor (EGF) was radioiodinated by six different direct iodination methods. The 1251-labeled EGF preparations were distinguished by analyzing the binding of the radioligand to the EGF receptor (EGFR)-containing human placental membranes. The receptorbinding affinityof EGF labeled with Chloramine T was less than the affinity of unlabeled EGF, which precluded an accurate determination of the specific radioactivityof the '25l-labeled EGF preparation by "self-displacement anal- 1, 2, 8-10, 18, 19) . lodination of EGF has been established either directly, by oxidation of the radioiodide in the presence of the polypeptide (1, 2,9,10,18), or indirectly, for human EGF, by conjugating EGF with a radioiodine-containing acylating agent (Bolton-Hunter reagent) (19, 20) . The oxidation of the radioiodide can be performed either chemically or enzymatically. For chemical oxidation, various agents are available, of which Chloramine T has been used the most extensively (2) (3) (4) (5) (6)(7). Despite its widespread acceptance, however, the Chloramine T method, in which the oxidizing agent is in solution, appears to damage the polypeptide to be iodinated (21-23). In contrast, methods involving a sparingly soluble oxidizing agent (lodogentm) or agents coupled to a solid support (lodobeadstm, Protag-125tm) have been claimed to be more gentle because direct contact between the oxidizing agent and the protein to be radiolabeled is minimized (8, 9, 18, 24-26). In the present study, we performed six different methods for direct iodination of mouse EGF. The binding behavior of the different radioligands to human placental membranes (HPM) containing EGFR was investi.-gated by comparing the saturation binding curves (increasing concentrations of iesIlabeled EGF) and the competitive binding curves (competition of 125I-labeled
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. lodination of EGF has been established either directly, by oxidation of the radioiodide in the presence of the polypeptide (1, 2,9,10,18), or indirectly, for human EGF, by conjugating EGF with a radioiodine-containing acylating agent (Bolton-Hunter reagent) (19, 20) . The oxidation of the radioiodide can be performed either chemically or enzymatically. For chemical oxidation, various agents are available, of which Chloramine T has been used the most extensively (2) (3) (4) (5) (6) (7) . Despite its widespread acceptance, however, the Chloramine T method, in which the oxidizing agent is in solution, appears to damage the polypeptide to be iodinated (21-23). In contrast, methods involving a sparingly soluble oxidizing agent (lodogentm) or agents coupled to a solid support (lodobeadstm, Protag-125tm) have been claimed to be more gentle because direct contact between the oxidizing agent and the protein to be radiolabeled is minimized (8, 9, 18, 24-26). Enzymatic oxidation of the radioiodide with lactoperoxidase can also be achieved both in the solubilized state (27,28) and, more mildly, in the solid state (10, 29). In the latter case, Sepharose-coupled lactoperoxidase (29) or lactoperoxidase and glucose oxidase immobilized on hydrophilic spheres (Enzymobeads'TM),are used (10).
In the present study, we performed six different methods for direct iodination of mouse EGF. The binding behavior of the different radioligands to human placental membranes (HPM) containing EGFR was investi.-gated by comparing the saturation binding curves (increasing concentrations of iesIlabeled EGF) and the competitive binding curves (competition of 125I-labeled EGF with unlabeled EGF) of the various products in an attempt to establish whether receptor-binding equivalence could be achieved between radioiodinated EGF and its unlabeled counterpart.
The effect of nonequivalence in binding behavior between labeled and unlabeled EGF was investigated by performing Scatchard analysis of saturation and competitive binding data. We also assessed the maximal binding capacity of each 1251..labeled EGF preparation to HPM, i.e., the fraction of the tracer that would bind at infinite receptor concentrations, to observe whether nonequivalence in binding behavior between labeled and unlabeled EGF could be explained by a decrease in binding capacity of the 125I4abeled EGF preparation. 
Materials and Methods

Materials
Preparationof HPM
Placental tissue was dissected free of total membranes and fleeces and homogenized in 1 mL of ice-cold Tris buffer (per liter, 20 minol of Tris -HC1, 250 mnmol of sucrose, 2 mmol of MgCl2, and 2 mmol of KC1, pH 7.6) per gram of tissue for 10 s, three times, in a Waring Blendor (high setting). After centrifugation for 20 mm at 800 x g, the pellet was rehomogenized in the same volume of Tris buffer with the Waring Blendor and centrifuged for 20 miii at 800 x g. The pellet obtained after this centrifugation step was discarded. The supernatant fractions from both centrifugation steps were pooled and centrifuged for 30 miii at 10 000 x g, and the resulting pellet was also discarded. The membrane fraction was obtained by centrifuging the supernate for 40 mm at 45000 x g. The pellet was resuspended in 1 mL of buffer A (per liter, 20 mmol of phosphate, 150 mmol of NaCl, and 50 imol of bacitracin, pH 7.4) per grain of placenta tissue (initial weight). All procedures were performed at 0-4 #{176}C. The membrane preparation was stored at -80 #{176}C in 1-mL aliquots. Jodo-beads method. According to the manufacturer's instructions, we mixed 10 zL of EGF with 180 pL of 0.1 moL'L phosphate buffer (pH 7.0) and 10 L (1 mCi) of Na'25!. The reaction was initiated by the addition of one lode-bead. After 2 miii of incubation, 1 mL of 0.1 molJL phosphate buffer (pH 7.0) was added and the reaction was stopped by loading the reaction mixture without the lode-bead onto a C,8 SPE column. Free iodine was removed as described above. The efficiency of the lodebead iodination reaction was 40-55%.
Iodine monochioride method. We performed the iodine monochloride method as described by Contreras et al. at 1 x g, after which the supernate was loaded onto an SPE column for removal of free iodine as described above. The efficiency of the Protag iodination reaction was 30-40%. Lactoperoxidase-glucose oxidase method (Enzymobeads). lodination was performed according to the manufacturer's instructions. We mixed 10 ML of EGF solution, 50 MLof 0.2 mol/L phosphate buffer (pH 7.4), 50 ML ofEnzymobead reagent, and 10 ML(1 mCi) of Na125I and added 25 iL of 10 g/L /3-D-glucose solution to start the reaction. After incubation for 10 miii, 1 mL of 0.2 mol/L phosphate buffer (pH 7.4) was added. Unbound iodine was removed by SPE as described above. Iodine was incorporated with 40-50% efficiency.
Specific Radioactivityand Ugand Equivalence
We determined the specific radioactivity of '251-labeled EGF preparations by the "self-displacement" method (31, 32), plotting bound/total (B/T) ratios vs radioactivity of '251-labeled EGF or mass of unlabeled EGF added to the receptor preparation.
We separated free and receptor-bound ligand by using HAP as previously described (11, 33). HAP adsorbs EGFR protein, leaving nonbound EGF in solution. Only low-speed centrifugation is required subsequently for the separation step.
We performed two sets of binding experiments, using For the saturation curve, the binding data were trans.-formed into BIT ratios and plotted on a semilogarithmic scale against the radioactivity added to the receptor preparation, after subtraction of the initial 2 x io counts/nun added in the first tube. For the competitive binding curve, the binding data were transformed into BIT ratios and plotted vs femtomoles of unlabeled EGF added, in the same semilogarithmic plot. At several BIT ratios in this plot, counts/mm of '251-labeled EGF and femtomoles of unlabeled EGF were read from the saturation curve and the competition curve, respectively. The counts/mm of '25I-labeled EGF obtained were plotted vs the corresponding femtomoles of unlabeled EGF. From the straight line obtained, the specific radioactivity of the tracer preparation can be obtained as the slope of this line (31).
Another plot was constructed from the saturation and competitive binding data, yielding the Ligand Equivalence (LE) plot. The apparent specific radioactivity calculated at various BIT ratios [log (counts/min) -log (fmol) = log (specific radioactivity in counts/mm per femtomole)] was converted into specific radioactivity in kCi/mol and plotted vs the BIT ratio at which this specific radioactivity was obtained. According to Hollemans and Touber (34) , if a radioligand has the same affinity as the unlabeled ligand, the line obtained in the LE plot is horizontal. There is nonequivalence in binding behavior between labeled and unlabeled ligand when the slope of this line differs significantly from zero (34).
Maximal BindingCapacity
About 2 x io counts/mm of EGF was equilibrated in duplicate with increasing amounts of 11PM (4- ing conditions: 100 MLof the incubate was added to an HAP pellet, which was obtained by centrifuging 100 ML of HAP suspension and subsequently aspirating the supennate. After incubation for 1 h at 20#{176}C with repeated mixing, the samples were centrifuged for 2 miii at 1000 x g (20 #{176}C). We then counted the radioactivity of 50 MLof the supernate (representing 50% of the free ligand) and the bound fraction was calculated by subtracting the nonbound '25!-labeled EGF from the total radioactivity added to the HAP pellet. A plot of 1/radioactivity bound vs 1/volume of the membrane preparation was constructed, such that the ordinate represented the fraction of '25!-labeled EGF that would bind at infinite receptor concentrations (maximal binding capacity) (19, 31).
Reaufta
We iodinated mouse EGF with Na125! by using six Figure ic) in which the apparent specific radioactivity, calculated at various BIT ratios, was plotted vs the BIT ratio at which this specific radioactivity was obtained (LE plot). As shown in Figure lb and c, the specific radioactivity decreases at increasing BIT ratios. The slope of this line differs considerably from zero, which implies that the affinity of the '251-labeled EGF labeled with Chlorainine T was lower than that of the unlabeled EGF (34) . Attempts to determine the specific radioactivity of Chioranune T-'25I-labeled EGF by extrapolation to BIT = 1 (34) also failed because most of the LE plots showed curvilinearity (n = 4); moreover, even a negative value was obtained in one experiment. Using commercially prepared '25!-labeled EGF (Chloranuine T method), the results of these binding experiments were essentially identical to those shown in Figure 1 obtained with Chloramine T-125I-labeled EGF prepared in our laboratory. Because the specific radioactivity of these commercially supplied '251-labeled EGF preparations is given by the manufacturer, we could perform Scatchard analyses (35) of saturation and competitive binding data to observe the effect of using labeled or unlabeled EGF as a variable in an EGFR assay. As demonstrated in Figure 2 , the apparent number of binding sites obtained from the competition analysis was lower than the apparent number of binding sites obtained when we used increasing concentrations of '25I-labeled EGF (24 and 49 pmol/L, respectively). Moreover, the apparent dissociation constant (Kd) was considerably higher when we used the latter method (0.20 and 0.65 nmol/L, respectively).
In the literature, iodinated ligands prepared with lodogen or lode-beads have been described as undergoing a milder iodination procedure (8, 9). In the present (Figure la) , i.e., diverging saturation and competition curves (data not shown). On the other hand, parallel binding curves were obtained when we used 1I-labeled EGF labeled by the IC1 method (Figure 3a) . As a consequence of this parallelism, a perfectly straight line was obtained with counts/mm of 125I-labeled EGF plotted vs femtomoles of unlabeled EGF (Figure 3b) , and a straight and horizontal LE plot could be constructed (Figure 3c) , indicating equivalence in binding behavior between labeled and unlabeled EGF. The specific radioactivity of ICl-'I-labeled EGF, which could be calculated accurately from the slope of the line in Figure 3b , was 415 ± 123 kCi/mol (mean ± SD, n = 5). Scatchard plots derived from saturation and competitive binding data did not show significant differences with respect to the apparent number of receptors (42 and 39 pmoJ/L, respectively) and apparent dissociation constants (0.27 and 0.24 nmol/L, respectively) ( Figure 4) .
Equivalence in binding behavior between labeled and unlabeled EGF could also be observed by using 1I labeled EGF iodinated with Protag-125 and Enzymebeads. The specific radioactivities were 525 ± 146 (n = 9) and 570 ± 80 kCilmol (n = 7) for 1I-labeled EGF labeled with Protag and Enzymobeads, respectively. Similar to observations for ICl-1I-labeled EGF, Scatchard plots obtained from saturation and competitive binding data with 125I-labeled EGF labeled with Protag or Enzymobeads were not different (data not shown). For all EGF tracers prepared by the six different methods (n = 35), the nonspecific binding ranged from 1% to 2% of the total counts added and the nonspecific adsorption to HAP (blank HAP) ranged from 0.6% to 1.7%. 
DiscussIon
Binding studies of EGFR require an '25I-labeled EGF preparation of which the binding behavior towards the receptor is identical to that of unlabeled EGF (15) . Moreover, an actual and accurate value for the specific radioactivity of the radioiodinated EGF is required (36). In the present study, we compared six direct methods for radioiodination of mouse EGF. The binding behavior of the different 'WI-labeled EGF preparations, as compared with that of unlabeled EGF, was investigated by comparison of saturation (increasing concentrations of 1251-labeled EGF) and competitive (fixed concentration of 1I-labeled EGF and increasing concentrations of unlabeled EGF) binding data. This comparison of saturation and competitive binding data is generally confusingly designated as self-displacement analysis (31,32). We prefer the term Ligand Equivalence Analysis (LEA). With LEA, an accurate determination of the specific radioactivity can be performed when the affinity of labeled and unlabeled ligand towards the receptor is identical. If these affinities are not identical, the slope of the LE plot differs from zero (34) . We performed experiments to study the binding behavior of EGF preparations labeled with Chloramine T to HPM containing EGFR. Apparently, the affinity of this radioligand was less than the affinity of unlabeled EGF. This nonequivalence between labeled and unlabeled EGF precludes an accurate determination of the specific radioactivity by LEA. Moreover, the LE plot in Figure ic There are other approaches besides LEA for determination of specific radioactivity. In many studies, the specific radioactivity of the radioligand is measured simply by determining the mass of the ligand and the corresponding radioactivity. The use of specific radioactivity obtained in this way, in concert with nonequivalence in binding behavior between labeled and unlabeled ligand, has important consequences in binding studies. For a tracer with a lower affinity than unlabeled EGF, displacement analysis will result in an underestimated EGFR value, whereas for a tracer with a higher affinity, an overestimation of the receptor number will be obtained. In contrast, saturation analysis will result in correct values for the number of binding sites, but the apparent dissociation constant will be incorrect to an extent that depends on the affinity of the tracer compared with that of unlabeled EGF.
lodogen and lode-beads have been claimed to be mild iodination reagents, compared with Chiorainine T, because of their insolubility in water (24-26). Our results, however, do not support this claim as far as iodinating EGF is concerned. The decrease in receptor-binding affinity of EGF labeled with Chioramine T, lodogen, or lode-beads could be due to oxidation of readily oxidizable amino acid residues in the EGF molecule-binding region (e.g., methionine and amino acids with aromatic side chains). Indeed, methionine is readily oxidized by Chloramine T treatment (37) . The oxidative capacity is probably not due to the iodination reagent itself, but more likely to oxidative intermediates formed in these procedures. When dissolved in water, Chioramine T, the n-monochloro derivative of p-toluenesulfonamide, generates hypochlorous acid (HOC1), a soluble and strongly oxidative molecule. lodogen (1,3,4,6-tetrachloro-3a,6a-diphenylglycouril) , a virtually insoluble complex with four Chloramine T-like groups (24, 25) , and lode-beads, Chioramine T molecules coupled onto polystyrene beads (26) , also generate HOC1 as an oxidative intermediate in the iodination reaction. Comparable oxidation damage to EGF therefore likely occurs when any of these methods is used. The probable oxidation of EGF by HOC1 from Chioramine T, lodogen, and lode-beads obviously has serious implications for the binding behavior of the labeled ligand.
The mechanism of the remaining three methods studied involves other intermediates to generate a reactive iodine molecule. IC1 acts via isotopic exchange (30). In the conventional lactoperoxidase method, a relatively high amount of hydrogen peroxide, which could be harmful for the peptide, is added to initiate the lactoperoxidase reaction (1). According to the manufacturer, Enzymobeads initiate the iodination reaction mildly by a very slow generation of hydrogen peroxide after conversion of $-D-glucose by glucose oxidase. Unfortunately, we do not know the mechanism of Protag-125 iodination, but it is likely to act differently from Chloramine T iodination. Iodination of EGF with Id, Protag-125, or Enzymobeads apparently does not affect the binding characteristics of EGF. This equivalence in binding behavior between labeled and unlabeled EGF suggests that none of these iodination methods results in substantial damage to the protein, at least in relation to its interaction with EGFR. Perhaps the tyrosine residues favored for iodination in these methods are not in the region of the protein moiety involved in the receptor interaction.
The unaltered binding behavior of these EGF preparations enables accurate measurements of the specific radioactivity. Moreover, a reliable estimation of EGF receptors by multiple-point Scatchard analysis can be established with respect to the apparent number of binding sites and apparent dissociation constants, both for saturation and competitive binding analyses. The 1mIlabeled EGF preparations so obtained are probably heterogeneous, but as we show in the present study the binding behavior of these tracers is identical to that of unlabeled EGF.
The observation that the mnima1 binding capacity of all six tracers is similar and still >95% is an indication that neither cysteine residues nor other amino acid residues critical for receptor binding are affected by Chloramine T, lodogen, and lode-beads, and that the probable oxidation of amino acid residues does not prevent, but only alters, the ligand-receptor interaction. We show clearly, in agreement with Kermode (15) , that maximal binding capacity and equivalence in binding behavior between labeled and unlabeled ligand are two separate aspects of radioligand quality, which both have to be examined before the radioligand is used in receptor studies.
Our present findings show that Chloramine T, lodogen, or lode-beads iodination affects the ligand-receptor interaction, resulting in a lesser receptor-binding affinity than that of unlabeled EGF. As a consequence, such ligands cannot be used for reliable measurements of EGF receptors. This holds particularly for those assays in which Scatchard analyses are performed by using a single amount of '25I-labeled EGF and increasing concentrations of unlabeled EGF. In contrast, 1251.. labeled EGF preparations with binding affinity towards EGFR identical to the affinity of the unlabeled growth factor could be prepared by using Id, Protag-125, or Enzymobeads. Sufficiently high specific radioactivities could be obtained with these methods. Therefore, sensitive and more-reliable EGFR assays can be performed by using EGF radioiodinated by these reagents.
